Sign in
4

Changes in Ownership

Alkermes plc. Filed Acc 0001127602-25-006718

EVP R&D, Chief Medical Officer gave up 8,866 shares (to pay taxes)

  • EVP R&D, Chief Medical Officer acquired 19,968 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hopkinson Craig C. · EVP R&D, Chief Medical Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-22 Exercise or conversion : show line 1 in the form +12,279 75,100 D
2025-02-22 Shares withheld for taxes : show line 2 in the form −5,452 $35.32 $192,565 69,648 D
2025-02-23 Exercise or conversion : show line 3 in the form +7,689 77,337 D
2025-02-23 Shares withheld for taxes : show line 4 in the form −3,414 $35.32 $120,582 73,923 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-02-22 Exercise or conversion : show line 5 in the form Restricted Stock Unit Award −12,279 0 D
2025-02-23 Exercise or conversion : show line 6 in the form Restricted Stock Unit Award −7,689 15,379 D
Loading xslF345X05/form4.xml…